Kai has broad experience leading strategic engagements with clients across the life sciences industry, including big and small pharma/biopharma companies and investors. He has worked in all the major therapeutic areas, with a deep expertise in oncology / immuno-oncology, ophthalmology, neurology, and rare diseases. Kai works across the product and organizational life cycle, with a specific interest in business development and licensing support, asset and therapeutic area strategy, and growth strategy. In partnering with clients, Kai works to bring a content-driven strategic perspective, driving to grounded and actionable recommendations.
Kai has 5+ years of experience in life sciences-related research and consulting. Prior to joining ClearView, Kai studied the mechanisms of cell division at Yale as well as bone regeneration at UCSF. He received his B.S. in molecular and cell biology from Yale.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Stephen Chang
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson